Skip to main content

Abstract

Background and Purpose—

Injury to the corticospinal tract (CST) has been shown to have a major effect on upper extremity motor recovery after stroke. This study aimed to examine how well CST injury, measured from neuroimaging acquired during the acute stroke workup, predicts upper extremity motor recovery.

Methods—

Patients with upper extremity weakness after ischemic stroke were assessed using the upper extremity Fugl-Meyer during the acute stroke hospitalization and again at 3-month follow-up. CST injury was quantified and compared, using 4 different methods, from images obtained as part of the stroke standard-of-care workup. Logistic and linear regression were performed using CST injury to predict ΔFugl-Meyer. Injury to primary motor and premotor cortices were included as potential modifiers of the effect of CST injury on recovery.

Results—

N=48 patients were enrolled 4.2±2.7 days poststroke and completed 3-month follow-up (median 90-day modified Rankin Scale score, 3; interquartile range, 1.5). CST injury distinguished patients who reached their recovery potential (as predicted from initial impairment) from those who did not, with area under the curve values ranging from 0.70 to 0.8. In addition, CST injury explained ≈20% of the variance in the magnitude of upper extremity recovery, even after controlling for the severity of initial impairment. Results were consistent when comparing 4 different methods of measuring CST injury. Extent of injury to primary motor and premotor cortices did not significantly influence the predictive value that CST injury had for recovery.

Conclusions—

Structural injury to the CST, as estimated from standard-of-care imaging available during the acute stroke hospitalization, is a robust way to distinguish patients who achieve their predicted recovery potential and explains a significant amount of the variance in poststroke upper extremity motor recovery.

Introduction

Upper extremity motor impairment is the most common source of disability after stroke,1 with the majority of spontaneous recovery occurring during the first 3 months.2,3 Prior studies have shown that for most patients, the magnitude of arm motor recovery is directly proportional to the severity of initial impairment.4–6 Currently, however, even experienced clinicians find it difficult to predict recovery.7 Being able to accurately predict recovery early after stroke has the potential to inform patient-specific recovery potential, guide rehabilitation strategies including discharge destination, and stratify patients into recovery-focused clinical trials.8–10
The corticospinal tract (CST) is an important pathway for voluntary dexterous upper extremity movement, as well as for upper extremity motor recovery.11 Structural and functional measures of integrity of the CST—specifically the presence of motor evoked potentials induced by transcranial magnetic stimulation12 and fractional anisotropy values derived from diffusion tensor imaging13,14—have been used to predict motor recovery after stroke,15,16 but these methods require dedicated research imaging methods17 and are currently not widely clinically available equipment.18 Methods that use common clinical imaging,19 without the necessity for dedicated additional scanning or specific equipment, have the substantial potential benefit of being readily and widely applicable early after stroke, across different clinical sites, and large numbers of patients.
Prior studies that have calculated structural injury to the CST using clinically available imaging after stroke have used heterogeneous methods.19–23 The general approach requires a CST template, individual stroke lesion maps, and a method for calculating the overlap between the two, but the templates used and methods of overlap vary substantially. No study has yet systematically compared different methods for estimating CST injury from acute stroke imaging with the goal of predicting spontaneous upper extremity motor recovery. Analysis of clinically available imaging also enables quantification of injury to other brain areas beyond the CST known to be important for motor recovery after stroke, for example, the primary motor cortex (M1) and premotor cortex (PM).21,24–26 Studies to date have not yet quantified the relative contribution of CST, PM, and M1 and the interactions among them to predict spontaneous or therapy-related motor recovery after stroke.
The primary aim of this study was to examine how well CST injury predicts upper extremity motor recovery using neuroimaging acquired during the acute stroke workup. Our hypothesis was that CST injury estimated from acute stroke images has significant predictive value for upper extremity motor recovery. Secondary aims included (1) comparing prediction performance of 4 different CST injury methods and (2) assessing the effect of PM and M1 injury on arm recovery.

Methods

The data and analysis code that support the findings of this study are available from the corresponding author on reasonable request.

Subject Recruitment

Patients were recruited from an ongoing, prospective, single-center natural history study of recovery of upper extremity weakness after stroke, the SMaHRT (Stroke Motor Recovery and Rehabilitation Study; https://www.clinicaltrials.gov, NCT03485040). From June 2017 to December 2018, eligible stroke patients with upper extremity weakness were screened from the Massachusetts General Hospital inpatient stroke service (detailed inclusion/exclusion in Methods in the online-only Data Supplement). All participants in the study provided written informed consent. The Institutional Review Board at Partners Healthcare approved the study.

Research Testing and Outcome Measures

Baseline information on age, sex, ethnicity, handedness, affected arm, premorbid disability, National Institutes of Health Stroke Scale, prior stroke, treatment status with respect to tPA (tissue-type plasminogen activator) or endovascular therapy, and infarct location were recorded for all participants at the time of enrollment. At follow-up, the presence of poststroke depression (defined by Patient Health Questionnaire score >427), whether patients were taking antidepressants (fluoxetine, other selective serotonin reuptake inhibitor, or other non-selective serotonin reuptake inhibitor antidepressant), and 90-day modified Rankin Scale were recorded. Participants were assessed with standard rehabilitation outcome measures including the upper extremity Fugl-Meyer (FM)28,29 during the acute stroke hospitalization (FMinit) and again at 3-month follow-up (FM3mo). Trained occupational therapists and researchers performed the upper extremity FM evaluation—a reliable and validated measure of motor impairment after stroke. Assessors who collected outcome measures were not involved in treating patients. Each patient participated in standard therapy between study enrollment and 3-month follow-up.

Image Processing and Lesion Mapping

Stroke topography was determined using magnetic resonance diffusion weighted images obtained as part of the standard-of-care acute stroke inpatient workup. In the case of multiple magnetic resonance image sequences performed during the acute stroke hospitalization, preference was given to scans closest to the inpatient research assessment date. In one case, magnetic resonance imaging was clinically contraindicated, and the patient’s CT scan was used. Methods for normalizing brain images to templates based on mixed CT and magnetic resonance imaging modalities are well established.30 Lesions were manually traced on diffusion weighted image/apparent diffusion coefficient volumes using FSL (https://fsl.fmrib.ox.ac.uk/fsl/fslwiki) by research staff (A.M.C. and F.G.) and independently verified by 2 board-certified neurologists (D.J.L. and S.B.S.). This manual segmentation process takes ≈20 to 30 minutes to perform depending on the size and complexity of the lesion, plus a few minutes to run scripts for spatial transformation and metric extraction (see Methods in the online-only Data Supplement for further details). Figure 1A shows the lesion overlap maps for the participants in this study.
Figure 1. Stroke lesions and corticospinal tract (CST), primary motor cortex (M1), PM templates. A, Stroke lesion overlap maps for the 48 participants. All lesions were flipped onto the left hemisphere for display. Color bar on the right with maximum value 22 (ie, maximal overlap voxel, red). B, M1-CST templates constructed using deterministic tractography methods. The light blue tract shows an M1-CST from 17 healthy controls at the University of California at Irvine (UCI). The green tract shows an M1-CST from 28 health subjects at Johns Hopkins University (JHU). Note the tracts are slightly offset and that the JHU tract traverses down to the level of the medulla while the UCI tract stops at the level of the mid-pons. C, Templates of dorsal premotor (pink) and ventral premotor (red) CSTs. D, Templates of primary motor (M1, dark blue) and premotor (yellow) cortices overlaid on the JHU CST template (green).

CST Injury

Two separate canonical M1-CST (unilateral M1 seed region) templates were used in this study (Figure 1B). One was generated at the University of California Irvine with 17 healthy, right-handed subjects using diffusion-weighted images obtained at 3T as described previously.24 The other M1-CST tract was from the Johns Hopkins University white matter tractography atlas,31 which averages the deterministic tractography of 28 healthy subjects and is available as part of the FSL software package. Note that the Johns Hopkins University tract traverses down to the level of the medulla while the caudal aspect of the University of California Irvine tract ends at the mid-pons. CST tracts from unilateral premotor seed regions, specifically dorsal PM (PMd) and ventral PM (PMv), were also included (Figure 1C). PMd and PMv-CST tracts were generated from 12 healthy right-handed subjects with tractographic methods for generating probability pathways connecting PMd and PMv to the cerebral peduncle as described previously.24
For each CST template, 4 different and previously published methods for estimating CST injury were implemented (Figure 2). In the first method, CST injury was calculated on the transverse slice of the CST with the greatest lesion overlap.21 In the second and third methods, raw and weighted-CST lesion loads, respectively, were calculated as described previously.23 In the final method, each CST was divided into 16 longitudinal subsections aimed at modeling the trajectory of groups of axons. The extent of injury to each subsection was quantified by measuring the volume of overlap between that subsection and the stroke mask. We then used the previously applied threshold of 5% overlap to designate the subsection injured by the stroke and, furthermore, determined the percentage of subsections injured by the stroke.24 All CST injury methods were implemented in MATLAB (Mathworks, Inc, Natick, MA).
Figure 2. Different methods for estimating corticospinal tract (CST) injury. There are a variety of methods for calculating CST injury from a given stroke lesion and CST template. A, One method uses area overlap between the stroke lesion and binarized CST tract on the axial slice with maximal overlap. Left, Coronal binarized CST tract; (middle) axial slice with maximal overlap between stroke and CST; (right) zoomed overlap of stroke (red) and CST template (blue). The number of voxels overlapped (red-blue overlay) is divided by the total number of blue voxels. B, In calculating 3-dimensional volume overlap between stroke (red) and CST (blue), raw and weighted values are incorporated into CST weighting to account for the probabilistic nature of the CST and narrowing of the CST at different points (ie, the posterior limb of the internal capsule). Left, Probabilistic nature of CST in a coronal slice. Middle highlights the weighted nature of the tract with purple to light blue color bar. The horizontal lines indicate corresponding axial slices of the CST that are shown on the right. C, Another method divides the CST into a number of rostral-caudal strands (16 in this case) and calculates %injury to each strand. If any given strand is lesioned by >5%, the strand is classified as injured. Right, Middle, and Left, coronal, sagittal, and axial slices, respectively, with CST strands in different colors (gray-blue gradient) and with stroke lesion shown in red.

Injury to Primary Motor and Premotor Cortices

Templates of M1 and PM, which include PMd and PMv cortices (Figure 1D), were obtained from the Julich Histological Atlas32 available as part of the FSL software package. These templates were binarized. Injury to M1 and PM was quantified by calculating the volume overlap between the respective binarized template and stroke masks. Given that M1 and PM injury were tightly correlated (Pearson R, 0.9), M1 and PM were treated as a single region of interest, M1-PM.

Statistical Analysis

Recovery was defined as change in FM between initial testing and 3-month follow-up:
The potential for recovery was the difference between initial FM and the maximum possible FM score:
Methods for distinguishing proportional from limited recoverers have previously been described4–6 and are detailed in Methods in the online-only Data Supplement.
The Kolmogorov-Smirnov test was used for unadjusted comparison of the performance of different CST injury methods in their ability to distinguish proportional from limited recoverers. Adjusted comparison controlled for lesion volume using multivariate logistic regression. To understand the effect of clinical characteristics including age, handedness, affected arm, depression, antidepressant use, premorbid disability, acute stroke treatment, prior stroke, stroke location, and subscales of the National Institutes of Health Stroke Scale (aphasia, neglect, sensory deficit) on recoverer status (proportional versus limited recovery), Kolmogorov-Smirnov, Fisher exact, and χ2 tests were performed for continuous and ordinal, dichotomous, and nominal values, respectively.
To further understand the ability of different CST injury methods to explain recovery, each individual’s FM change was normalized by their potential for recovery to determine their realized recovery:
This measure varies from 0 to 1 and accounts for initial injury. The rationale for this normalization is that an individual who starts at an FMInit of 58 and recovers to 64 at 3 months would be hypothesized to have a different (ie, much smaller burden of) CST injury from an individual who starts at an FMInit of 4 and recovers to 10. Note that normalizing recovery in this way accounts for the proportional recovery model assumption that initial injury explains the vast amount of variance in change. We performed Pearson correlation and calculated the R2 between values for each CST injury method and realized FM recovery.
Finally, to understand the influence of cortical injury on the relationship between CST injury and recovery, hierarchical linear regression including CST injury, M1-pM injury, and the interaction term was performed. Statistical analyses were performed in MATLAB (Mathworks, Natick, MA).

Results

Study Subjects

A total of 65 patients with upper extremity weakness after ischemic stroke consented for this study and had initial research measures collected during their acute stroke hospitalization. N=48 participants completed their 90-day research follow-up at the time of this analysis. Reasons for not completing the 90-day research follow-up included death (4), recurrent stroke (4), lost to follow-up (6), study withdrawal (1), and inability to complete follow-up research assessments because of time (1) and pain (1). Participants were assessed within 4.2±2.7 (mean±SD) days and again 85.4±7.3 days after stroke onset. Baseline and stroke characteristics are summarized in Table 1 and provided for individual participants in Table I in the online-only Data Supplement.
Table 1. Participant Characteristics
 Total Sample (n=48)Proportional Recoverers (n=31)Limited Recoverers (n=17)P Value
Age, y64.81±1.6765.61±1.5963.35±3.770.73
Sex (Male)25 (52.1)19 (61.3)6 (35.3)0.13
Ethnicityχ2=0.60, P=0.74
 White42 (87.5)27 (87.1)15 (88.2) 
 Black5 (10.4)3 (9.7)2 (11.8)
 Hispanic1 (2.1)1 (3.2)0
Dominant hand (right)39 (81.3)27 (87.1)12 (70.6)0.25
Affected arm (right)23 (47.9)17 (54.8)6 (35.3)0.24
Depression (follow-up)13 (27.1)7 (22.6)6 (35.3)0.5
Antidepressant useχ2=4.34, P=0.23
 Fluoxetine28 (58.3)15 (48.4)13 (76.5) 
 Other SSRI5 (10.4)4 (12.9)1 (5.9)
 Non-SSRI6 (12.5)4 (12.9)2 (11.8)
Premorbid mRS0 [1]0 [0.75]0 [2]0.14
Prior stroke9 (18.8)7 (22.6)2 (11.8)0.46
Acute stroke therapy
 tPA16 (33.3)12 (38.7)4 (23.5)0.35
 EVT10 (20.8)6 (19.4)4 (23.5)0.73
Stroke locationχ2=1.84, P=0.61
 MCA37 (77.1)25 (80.7)12 (70.6) 
 PCA2 (4.2)1 (3.2)1 (5.8)
  Brainstem4 (8.3)3 (9.7)1 (5.8)
 Multifocal5 (10.4)2 (6.5)3 (17.7)
Initial NIHSS7.5 [7]5 [3.75]13 [7.25]<0.001
 Aphasia10 (20.8)7 (22.6)3 (17.7)1
 Neglect13 (27.1)5 (16.1)8 (47.1)0.46
 Sensory deficit21 (43.8)12 (38.7)9 (52.9)0.34
Initial FM20.5 (48.5)44 (34)4 (3.5)<0.001
FM 3 mo58 (46.5)63 (7.5)9 (14.25)<0.001
90-d mRS3 (1.5)2 (2)4 (1)<0.001
Statistics are presented as mean±SE, n (%), and median [IQR]. Kolmogorov-Smirnov, Fisher exact, and χ2 tests were performed for continuous (age, total NIHSS) and ordinal (mRS), dichotomous (sex, dominant hand, affected arm, depression, prior stroke, acute stroke therapies, and presence of aphasia, neglect, or sensory deficit), and nominal (ethnicity, antidepressant use, and stroke location) values, respectively. EVT indicates endovascular therapy; FM, Fugl-Meyer; IQR, interquartile range; MCA, middle cerebral artery; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; PCA, posterior cerebral artery; SSRI, selective serotonin reuptake inhibitor; and tPA, tissue-type plasminogen activator.

CST Injury Methods Distinguish Proportional Spontaneous Recoverers From Limited Recoverers

There were 31 proportional recoverers and 17 limited recoverers (Figure 3). The group of limited recoverers on average started with initially severe arm impairment (FM<22) and experienced a median of 10% of their potential for FM recovery, in contrast to the group of proportional recoverers who on average started with FM≥22 and realized a median of 86% of their arm recovery potential (P<0.001). Four methods (maximum cross-sectional area overlap, raw lesion load, weighted lesion load, and 16-Divisions, 5% injury) for estimating CST injury from neuroimaging acquired during the acute stroke workup were compared for their ability to distinguish proportional recoverers from limited recoverers. First, there was high correlation between the 4 methods’ injury values, across all canonical CST tracts (University of California Irvine M1-CST, Johns Hopkins University M1-CST, PMd-CST, PMv-CST; Table II in the online-only Data Supplement). CST injury, regardless of method, tract, or seed region used, separated proportional from limited recoverers. This was true whether using unadjusted models or adjusted models that incorporated lesion volume (Table 2). Receiver operating characteristic analysis (Figure II in the online-only Data Supplement; Table III in the online-only Data Supplement) showed that area under the curve values for all 4 CST injury methods for distinguishing limited from proportional recoverers ranged from 0.70 to 0.8, indicating good discrimination ability.33 Note that area under the curve values for M1-CST tracts showed slightly better discriminatory ability (0.75–0.8; Table III in the online-only Data Supplement, top) than area under the curve values for PMd-CST and PMv-CST tracts (0.70–0.75; Table III in the online-only Data Supplement, bottom). In contrast to all CST injury methods, clinical characteristics including poststroke depression, antidepressant use, the presence of prior stroke, and the presence of aphasia or neglect were not significantly related to recoverer status (Table 1).
Table 2. Performance of Different CST Injury Methods for Distinguishing Proportional From Limited Recoverers
CST TemplateInjury MethodCST Injury ValueP (KS Test)P (Adjusted)*
  Proportional (n=31)Limited (n=17)  
UCI, M1Max area0.47±0.0610.75±0.0600.00800.017
UCI, M1RLL, cm30.86±0.142.0±0.350.00340.0042
UCI, M1WLL, cm31.42±0.223.26±0.560.00370.0058
UCI, M116/5%0.44±0.0630.75±0.0500.00670.013
JHU, M1Max area0.36±0.0440.64±0.061<0.0010.0022
JHU, M1RLL, cm30.26±0.040.68±0.12<0.0010.0037
JHU, M1WLL, cm30.50±0.081.23±0.210.00110.0037
JHU, M116/5%0.21±0.0380.47±0.0800.00470.0056
PMdMax area0.44±0.0480.66±0.0600.00700.021
PMdRLL, cm31.11±0.182.52±0.480.0120.0034
PMdWLL, cm31.77±0.274.02±0.690.00220.0020
PMd16/5%0.39±0.0570.65±0.0840.0150.022
PMvMax area0.42±0.0600.68±0.0790.0120.026
PMvRLL, cm30.64±0.131.51±0.360.0170.0088
PMvWLL, cm31.18±0.232.90±0.640.00530.0031
PMv16/5%0.37±0.0600.63±0.0850.0250.026
Lesion volume, cm335.0±10.353. 6±16.20.14
Values are presented as mean±SE. 16/5% indicates 16 divisions, 5% injury threshold; CST, corticospinal tract; JHU, Johns Hopkins University; KS test, Kolmogorov-Smirnov test; M1, motor cortex; Max area, maximum cross-sectional area; PMd, dorsal premotor cortex; PMv, ventral premotor cortex; RLL, raw lesion load; UCI, University of California at Irvine; and WLL, weighted lesion load.
*
Logistic regression adjusted for lesion volume.
Note that UCI template calculations could not be performed on 5 of 48 (3 proportional and 2 limited recoverers) participants because these participants had injury that extended below the level of the mid-pons. JHU template calculations were performed on all 48 participants.
Figure 3. Proportional and limited recoverers. A, Upper extremity Fugl-Meyer (UE-FM) recovery curves between hospital admission and 3-mo follow-up for 48 patients with stroke. Note that in severe patients (Fugl-Meyer [FM]Init, <22), there is a group with limited recovery (dark gray lines). B, Potential for 66−FMInit vs actual FM3mo−FMInit recovery of upper extremity impairment. The line (black-dashed) represents the amount of recovery as predicted by the proportional recovery model (FMPredicted, 0.7×FMPotential). Limited recoverers (dark gray squares) are distinguished from proportional recoverers (light gray circles) by a model residual of >10 from their 70% predicted recovery. The histogram inset shows the model residuals of proportional recoverers (light gray) and limited recoverers (dark gray).

CST Injury Explains ≈20% of Individual Variance in Spontaneous Motor Recovery

Next, we sought to extend these findings regarding proportional versus limited recovery to understanding how CST injury explains variance in individual recovery. Realized recovery (a measure of recovery adjusted for extent of possible recovery) was examined in relation to CST injury values generated using each of the CST injury methods. M1-CST injury, across each method and both canonical M1-CST tracts, was related to realized recovery across all subjects with R2 values ranging from 0.18 to 0.25 (Figure 4A and 4B, all P<0.01). PMd- and PMv-CST injury, across each method, although still significant, had less strong relationships with realized recovery with R2 values ranging from 0.08 to 0.20 (Figure 4C and 4D, all P<0.05). Structural injury to the CST significantly explains ≈20% of the variance in upper extremity motor recovery even after adjusting for initial motor deficits.
Figure 4. Scatter plots of realized recovery against all different corticospinal tract (CST) injury method values. A, University of California at Irvine (UCI) motor cortex (M1)-CST, (B) Johns Hopkins University (JHU) M1-CST, (C) dorsal premotor (PMd)-CST, and (D) ventral premotor (PMv)-CST. Least square fit lines and corresponding R2 correlation coefficients are shown.

Adding Measures of Motor and PM Injury Does Not Affect the Relationship Between CST Injury and Recovery

A total of 21 patients sustained injury to M1-PM while 27 had no injury. In contrast to CST injury, the total amount of injury to M1-PM did not separate proportional from limited recovery in both unadjusted (P=0.54) and adjusted (P=0.17) models. Total amount of M1-PM injury also did not significantly explain variance in realized recovery (R2=0.1, P=0.08).
We chose the cross-sectional overlap method on the Johns Hopkins University tract as our primary CST injury method because it achieved the greatest R2 and could be performed in all patients in the cohort including those with stroke lesions below the level of the mid-pons. In a hierarchical linear regression analysis (Table V in the online-only Data Supplement), CST injury explained 24.8% of the variance in realized recovery (model 1) and addition of M1-PM injury did not significantly change the R2 (model 2). Model 3 included CST injury, M1-PM injury, and their interaction term to determine whether the presence of M1-PM injury moderated the relationship between CST and realized recovery. Although the slope of the interaction term was negative, suggesting that there was a trend toward M1-PM injury reinforcing the effect of CST injury on recovery, the interaction term was not significant. The results of models 2 and 3 were unchanged whether we included amount of M1-PM injury as a binary or continuous variable. Furthermore, structural injury to M1-PM did not significantly moderate the relationship between CST injury and realized recovery.

Discussion

The main findings in this study were (1) extent of CST injury distinguishes proportional recoverers from limited recoverers; (2) CST injury explained ≈20% of variance in the magnitude of upper extremity recovery, even after adjusting for initial motor deficits; and (3) injury to primary motor and premotor cortices did not significantly influence the predictive value that CST injury had on arm motor recovery. Importantly, these motor system injury measures were derived from neuroimages acquired as part of the acute stroke standard evaluation. Together, these findings suggest that acute imaging provides useful data for predicting behavioral recovery after stroke.
Predicting the extent to which a patient will recover after stroke is useful for informing clinical decision-making, as well as for stratification in clinical trials.8–10 Some methods proposed for predicting recovery after stroke require specialized research equipment or imaging techniques that are accessible only in advanced research centers.34 The current study, therefore, examined prediction of recovery using scans acquired as part of standard of care. We found that CST injury distinguished patients who achieved their predicted recovery from those who did not, regardless of method implemented or tract used. CST injury also significantly explained ≈20% of variance in the magnitude of individual recovery. This remained true after controlling for the severity of initial arm impairment.
Significant agreement was found between 4 different methods for estimating CST injury from acute stroke imaging, including raw and weighted lesion load. This suggests that these methods are relatively precise and that clinicians and investigators can likely pick their method and template of choice for estimating CST injury from acute stroke images. One prior study also used a similar approach, using raw- and weighted-CST lesion load derived from acute stroke imaging to predict upper extremity motor impairment outcomes at 3 months, and found that weighted lesion load performed best for prediction in their cohort.19 CST templates from primary motor as compared with premotor cortices allowed for better recovery prediction suggesting that the specificity of the cortical seed region is important for CST-related motor recovery.
Structural injury to primary motor and premotor cortices themselves did not significantly influence the relationship between CST injury and recovery. The relationship, however, was in the expected direction—M1-PM injury reinforced the negative effect of CST injury on recovery. The lack of significance may have been a reflection of the sample size (n=48) in this single-site study. Furthermore, standard template-based imaging assignments of cortical regions of interest may not precisely align with classical neuroanatomy or functional neurophysiology. To this end, the application of more recent approaches to cortical parcellation35 may prove useful for understanding recovery after stroke.
The current methods set the stage to use clinical standard-of-care stroke imaging to predict a patient’s extent of recovery after stroke. Measuring injury to a single white matter tract using acute stroke imaging significantly predicts recovery, but significant variance remains unexplained—there were cases in which proportional recoverers had substantial CST injury and limited recoverers had modest injury, although separation between the two groups was overall good with receiver operating characteristic area under the curve values of 0.7 to 0.8. Adding measures of neural function, such as transcranial magnetic stimulation15,16 or EEG,36 may improve the strength of prediction but are not currently part of the standard-of-care acute stroke evaluation. Much as neuroimaging guides decision-making in the context of reperfusion therapy decision-making, the same images can inform decision-making in a recovery-focused context.
There are a number of limitations to this study. As compared with national statistics, our study sample had a slightly younger mean age (65 in this study compared with 69 nationally37), had slightly more men (52% in this study compared with 47% nationally38), and was highly ethnically homogeneous (white), reflecting the patient population at our single center. Only one motor outcome measure was used in this study, the upper extremity FM, which may not reflect the complexity of motor and premotor system function. Including measures of complex motor behaviors (such as apraxia) with specific relationships to cortical areas and descending tracts may improve predictive ability. Similarly, including early and more sophisticated (beyond National Institutes of Health Stroke Scale subscales) measures of cofactors that would be hypothesized to influence motor recovery such as cognition, aphasia, neglect, sensation, handedness, and dominant/nondominant hemisphere of stroke injury would likely improve recovery prediction. Finally, estimating the topography of stroke injury from acute stroke diffusion images presents clear challenges. Our study relied on manual lesion segmentation, which is inherently subjective but currently remains the gold standard. In addition, there are a number of early stroke features that were not accounted for including poststroke edema, which may influence the neuroanatomic localization of the stroke lesion relative to motor/PMs or descending CSTs. Machine learning techniques applied to large datasets of stroke images and rehabilitation outcome measures may be helpful for both automating lesion segmentation and learning important imaging features.39

Conclusions

Structural injury to the CST estimated from standard-of-care imaging is a robust way to distinguish patients who achieve their predicted recovery from those who do not and explains a substantial amount of variance in poststroke upper extremity motor recovery. These methods provide a scalable model for subsequent stroke recovery studies. Predictors of stroke recovery have the potential to inform targeted development of stroke recovery therapeutics, stratify patients in clinical trials, and personalize neurorehabilitation clinical decision-making.40

Acknowledgments

The authors acknowledge Susan E. Fasoli for standardized upper extremity Fugl-Meyer training provided to research staff in this study and Amanda Duffy, Susan E. Fasoli, and Teresa J. Kimberley for helpful comments provided to the manuscript. Dr Lin, A.M. Cloutier, Dr Erler, Dr Cassidy, Dr Finklestein, Dr Hochberg, and Dr Cramer contributed to study concept and design; Dr Lin, A.M. Cloutier, Dr Erler, Dr Snider, J. Ranford, K. Parlman, and Dr Giatsidis participated in data acquisition and analysis; Dr Lin, Dr Erler, Dr Burke, Dr Schwamm, and Dr Cramer performed data and statistical analysis; Dr Lin, A.M. Cloutier, Dr Erler, Dr Cassidy, Dr Hochberg, and Dr Cramer drafted the manuscript and figures.

Supplemental Material

File (str_stroke-2019-025898_supp1.pdf)

References

1.
Langhorne P, Coupar F, Pollock A. Motor recovery after stroke: a systematic review. Lancet Neurol. 2009;8:741–754. doi: 10.1016/S1474-4422(09)70150-4
2.
Kwakkel G, Kollen B, Twisk J. Impact of time on improvement of outcome after stroke. Stroke. 2006;37:2348–2353. doi: 10.1161/01.STR.0000238594.91938.1e
3.
Duncan PW, Goldstein LB, Matchar D, Divine GW, Feussner J. Measurement of motor recovery after stroke. Outcome assessment and sample size requirements. Stroke. 1992;23:1084–1089. doi: 10.1161/01.str.23.8.1084
4.
Prabhakaran S, Zarahn E, Riley C, Speizer A, Chong JY, Lazar RM, et al. Inter-individual variability in the capacity for motor recovery after ischemic stroke. Neurorehabil Neural Repair. 2008;22:64–71. doi: 10.1177/1545968307305302
5.
Winters C, van Wegen EE, Daffertshofer A, Kwakkel G. Generalizability of the proportional recovery model for the upper extremity after an ischemic stroke. Neurorehabil Neural Repair. 2015;29:614–622. doi: 10.1177/1545968314562115
6.
Stinear CM, Byblow WD, Ackerley SJ, Smith MC, Borges VM, Barber PA. Proportional motor recovery after stroke: implications for trial design. Stroke. 2017;48:795–798. doi: 10.1161/STROKEAHA.116.016020
7.
Nijland RH, van Wegen EE, Harmeling-van der Wel BC, Kwakkel G; Early Prediction of Functional Outcome After Stroke Investigators. Accuracy of physical therapists’ early predictions of upper-limb function in hospital stroke units: the EPOS Study. Phys Ther. 2013;93:460–469. doi: 10.2522/ptj.20120112
8.
Stinear CM, Byblow WD, Ackerley SJ, Barber PA, Smith MC. Predicting recovery potential for individual stroke patients increases rehabilitation efficiency. Stroke. 2017;48:1011–1019. doi: 10.1161/STROKEAHA.116.015790
9.
Bernhardt J, Hayward KS, Kwakkel G, Ward NS, Wolf SL, Borschmann K, et al. Agreed definitions and a shared vision for new standards in stroke recovery research: the stroke recovery and rehabilitation roundtable taskforce. Int J Stroke. 2017;12:444–450. doi: 10.1177/1747493017711816
10.
Boyd LA, Hayward KS, Ward NS, Stinear CM, Rosso C, Fisher RJ, et al. Biomarkers of stroke recovery: consensus-based core recommendations from the stroke recovery and rehabilitation roundtable. Neurorehabil Neural Repair. 2017;31:864–876. doi: 10.1177/1545968317732680
11.
Rondina JM, Park CH, Ward NS. Brain regions important for recovery after severe post-stroke upper limb paresis. J Neurol Neurosurg Psychiatry. 2017;88:737–743. doi: 10.1136/jnnp-2016-315030
12.
Byblow WD, Stinear CM, Barber PA, Petoe MA, Ackerley SJ. Proportional recovery after stroke depends on corticomotor integrity. Ann Neurol. 2015;78:848–859. doi: 10.1002/ana.24472
13.
Bigourdan A, Munsch F, Coupé P, Guttmann CR, Sagnier S, Renou P, et al. Early fiber number ratio is a surrogate of corticospinal tract integrity and predicts motor recovery after stroke. Stroke. 2016;47:1053–1059. doi: 10.1161/STROKEAHA.115.011576
14.
Buch ER, Rizk S, Nicolo P, Cohen LG, Schnider A, Guggisberg AG. Predicting motor improvement after stroke with clinical assessment and diffusion tensor imaging. Neurology. 2016;86:1924–1925. doi: 10.1212/WNL.0000000000002675
15.
Stinear CM, Barber PA, Petoe M, Anwar S, Byblow WD. The PREP algorithm predicts potential for upper limb recovery after stroke. Brain. 2012;135(pt 8):2527–2535. doi: 10.1093/brain/aws146
16.
Stinear CM, Byblow WD, Ackerley SJ, Smith MC, Borges VM, Barber PA. PREP2: a biomarker-based algorithm for predicting upper limb function after stroke. Ann Clin Transl Neurol. 2017;4:811–820. doi: 10.1002/acn3.488
17.
Kim B, Fisher BE, Schweighofer N, Leahy RM, Haldar JP, Choi S, et al. A comparison of seven different DTI-derived estimates of corticospinal tract structural characteristics in chronic stroke survivors. J Neurosci Methods. 2018;304:66–75. doi: 10.1016/j.jneumeth.2018.04.010
18.
Hoonhorst MHJ, Nijland RHM, van den Berg PJS, Emmelot CH, Kollen BJ, Kwakkel G. Does transcranial magnetic stimulation have an added value to clinical assessment in predicting upper-limb function very early after severe stroke? Neurorehabil Neural Repair. 2018;32:682–690. doi: 10.1177/1545968318785044
19.
Feng W, Wang J, Chhatbar PY, Doughty C, Landsittel D, Lioutas VA, et al. Corticospinal tract lesion load: an imaging biomarker for stroke motor outcomes. Ann Neurol. 2015;78:860–870. doi: 10.1002/ana.24510
20.
Cassidy JM, Tran G, Quinlan EB, Cramer SC. Neuroimaging identifies patients most likely to respond to a restorative stroke therapy. Stroke. 2018;49:433–438. doi: 10.1161/STROKEAHA.117.018844
21.
Lam TK, Binns MA, Honjo K, Dawson DR, Ross B, Stuss DT, et al. Variability in stroke motor outcome is explained by structural and functional integrity of the motor system. Sci Rep. 2018;8:9480. doi: 10.1038/s41598-018-27541-8
22.
Burke Quinlan E, Dodakian L, See J, McKenzie A, Le V, Wojnowicz M, et al. Neural function, injury, and stroke subtype predict treatment gains after stroke. Ann Neurol. 2015;77:132–145. doi: 10.1002/ana.24309
23.
Zhu LL, Lindenberg R, Alexander MP, Schlaug G. Lesion load of the corticospinal tract predicts motor impairment in chronic stroke. Stroke. 2010;41:910–915. doi: 10.1161/STROKEAHA.109.577023
24.
Riley JD, Le V, Der-Yeghiaian L, See J, Newton JM, Ward NS, et al. Anatomy of stroke injury predicts gains from therapy. Stroke. 2011;42:421–426. doi: 10.1161/STROKEAHA.110.599340
25.
Seitz RJ, Höflich P, Binkofski F, Tellmann L, Herzog H, Freund HJ. Role of the premotor cortex in recovery from middle cerebral artery infarction. Arch Neurol. 1998;55:1081–1088. doi: 10.1001/archneur.55.8.1081
26.
Schulz R, Park E, Lee J, Chang WH, Lee A, Kim YH, et al. Interactions between the corticospinal tract and premotor-motor pathways for residual motor output after stroke. Stroke. 2017;48:2805–2811. doi: 10.1161/STROKEAHA.117.016834
27.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–613. doi: 10.1046/j.1525-1497.2001.016009606.x
28.
Fugl-Meyer AR, Jääskö L, Leyman I, Olsson S, Steglind S. The post-stroke hemiplegic patient. 1. a method for evaluation of physical performance. Scand J Rehabil Med. 1975;7:13–31.
29.
See J, Dodakian L, Chou C, Chan V, McKenzie A, Reinkensmeyer DJ, et al. A standardized approach to the Fugl-Meyer assessment and its implications for clinical trials. Neurorehabil Neural Repair. 2013;27:732–741. doi: 10.1177/1545968313491000
30.
Rorden C, Bonilha L, Fridriksson J, Bender B, Karnath HO. Age-specific CT and MRI templates for spatial normalization. Neuroimage. 2012;61:957–965. doi: 10.1016/j.neuroimage.2012.03.020
31.
Hua K, Zhang J, Wakana S, Jiang H, Li X, Reich DS, et al. Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification. Neuroimage. 2008;39:336–347. doi: 10.1016/j.neuroimage.2007.07.053
32.
Eickhoff SB, Paus T, Caspers S, Grosbras MH, Evans AC, Zilles K, et al. Assignment of functional activations to probabilistic cytoarchitectonic areas revisited. Neuroimage. 2007;36:511–521. doi: 10.1016/j.neuroimage.2007.03.060
33.
Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5:1315–1316. doi: 10.1097/JTO.0b013e3181ec173d
34.
Kim B, Winstein C. Can neurological biomarkers of brain impairment be used to predict poststroke motor recovery? a systematic review. Neurorehabil Neural Repair. 2017;31:3–24. doi: 10.1177/1545968316662708
35.
Glasser MF, Coalson TS, Robinson EC, Hacker CD, Harwell J, Yacoub E, et al. A multi-modal parcellation of human cerebral cortex. Nature. 2016;536:171–178. doi: 10.1038/nature18933
36.
Wu J, Srinivasan R, Burke Quinlan E, Solodkin A, Small SL, Cramer SC. Utility of EEG measures of brain function in patients with acute stroke. J Neurophysiol. 2016;115:2399–2405. doi: 10.1152/jn.00978.2015
37.
Kissela BM, Khoury JC, Alwell K, Moomaw CJ, Woo D, Adeoye O, et al. Age at stroke: temporal trends in stroke incidence in a large, biracial population. Neurology. 2012;79:1781–1787. doi: 10.1212/WNL.0b013e318270401d
38.
Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139:e56–e528. doi: 10.1161/CIR.0000000000000659
39.
Liew SL, Anglin JM, Banks NW, Sondag M, Ito KL, Kim H, et al. A large, open source dataset of stroke anatomical brain images and manual lesion segmentations. Sci Data. 2018;5:180011. doi: 10.1038/sdata.2018.11
40.
Lin DJ, Finklestein SP, Cramer SC. New directions in treatments targeting stroke recovery. Stroke. 2018;49:3107–3114. doi: 10.1161/STROKEAHA.118.021359

eLetters(0)

eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.

Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.

Information & Authors

Information

Published In

Go to Stroke
Go to Stroke

Versions

You are viewing the most recent version of this article.

History

Received: 3 June 2019
Revision received: 15 September 2019
Accepted: 27 September 2019
Published online: 25 October 2019
Published in print: December 2019

Permissions

Request permissions for this article.

Keywords

  1. area under curve
  2. humans
  3. neuroimaging
  4. neurological rehabilitation
  5. pyramidal tracts

Subjects

Authors

Affiliations

David J. Lin, MD [email protected]
From the Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston (D.J.L., A.M.C., F.G., L.R.H.)
Division of Neurocritical Care and Emergency Neurology, Department of Neurology (D.J.L., S.B.S., L.R.H.), Massachusetts General Hospital, Boston
Alison M. Cloutier, MS
From the Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston (D.J.L., A.M.C., F.G., L.R.H.)
Kimberly S. Erler, OTR/L, PhD
Department of Occupational Therapy, MGH Institute of Health Professions, Boston, MA (K.S.E.)
Jessica M. Cassidy, PhD, DPT
Division of Physical Therapy, Department of Allied Health Sciences, University of North Carolina at Chapel Hill (J.M.C.)
Samuel B. Snider, MD
Division of Neurocritical Care and Emergency Neurology, Department of Neurology (D.J.L., S.B.S., L.R.H.), Massachusetts General Hospital, Boston
Jessica Ranford, OTR/L, MS
Department of Occupational Therapy (J.R.), Massachusetts General Hospital, Boston
Kristin Parlman, PT, DPT
Department of Physical Therapy (K.P.), Massachusetts General Hospital, Boston
Fabio Giatsidis, MD
From the Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston (D.J.L., A.M.C., F.G., L.R.H.)
Department of Neurology, University of Rome Tor Vergata, Italy (F.G.)
James F. Burke, MD, MS
Department of Neurology, University of Michigan, Ann Arbor (J.F.B.)
Lee H. Schwamm, MD
Stroke Service, Department of Neurology (L.H.S., S.P.F.), Massachusetts General Hospital, Boston
Seth P. Finklestein, MD
Stroke Service, Department of Neurology (L.H.S., S.P.F.), Massachusetts General Hospital, Boston
Leigh R. Hochberg, MD, PhD*
From the Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston (D.J.L., A.M.C., F.G., L.R.H.)
Division of Neurocritical Care and Emergency Neurology, Department of Neurology (D.J.L., S.B.S., L.R.H.), Massachusetts General Hospital, Boston
VA RR&D Center for Neurorestoration and Neurotechnology, Rehabilitation R&D Service, VA Medical Center, Providence, RI (L.R.H.)
School of Engineering and Carney Institute for Brain Science, Brown University, Providence, RI (L.R.H.)
Steven C. Cramer, MD*
Department of Neurology, University of California, Irvine (S.C.C.).

Notes

Current address for Dr Cramer: Department of Neurology, University of California, Los Angeles; and California Rehabilitation Hospital, Los Angeles, CA.
*
Drs Hochberg and Cramer contributed equally.
The online-only Data Supplement is available with this article at Supplemental Material.
Correspondence to David J. Lin, MD, Harvard Medical School, 175 Cambridge St, Suite 300, Boston, MA 02114. Email [email protected]

Disclosures

Dr Lin has served as a consultant for Boehringer Ingelheim. Dr Finklestein is a Principal in Stemetix and a consultant to AZTherapies, Constant Therapeutics, Elevian, NeuroVasc, and Regenera. Dr Cramer has served as a consultant for Abbvie, Constant Therapeutics, MicroTransponder, Neurolutions, Regenera, SanBio, Stemedica, Fujifilm Toyama Chemical, Co, Biogen, and TRCare. Dr Hochberg has received funding from the American Heart Association (AHA; 19CSLOI34780000) for research unrelated to this project. Dr Schwamm reports serving as chair of the AHA/American Stroke Association Get With The Guidelines-Stroke clinical work group and the hospital accreditation Science Committee and Quality Oversight Committees and serving as a scientific consultant to LifeImage regarding user interface design and usability; to Penumbra for their Data and Safety Monitoring Commitee, Separator 3D, and Artemis in the Removal of Intracerebral Hemorrhage (MIND NCT03342664) trial; and to Medtronic for the Evaluation of the Phased Radio Frequency Ablation System (VICTORY-AF NCT01693120) and Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin (STROKE AF NCT02700945) trials.

Sources of Funding

This research was supported by the National Institutes of Health through R25NS065743 (Dr Lin) and K99HD091375 (Dr Cassidy), 2R44NS095381-02 (Dr Finklestein), the American Heart Association/Northeast Cerebrovascular Consortium pilot grant (Dr Lin), and the Massachusetts General Hospital Center for Neurotechnology and Neurorecovery.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

  1. Design and Preliminary Evaluation of a Soft Finger Exoskeleton Controlled by Isometric Grip Force, Machines, 12, 4, (230), (2024).https://doi.org/10.3390/machines12040230
    Crossref
  2. Responsiveness to exoskeleton loading during bimanual reaching is associated with corticospinal tract integrity in stroke, Frontiers in Neuroscience, 18, (2024).https://doi.org/10.3389/fnins.2024.1348103
    Crossref
  3. Moving toward elucidating alternative motor pathway structures post-stroke: the value of spinal cord neuroimaging, Frontiers in Neurology, 15, (2024).https://doi.org/10.3389/fneur.2024.1282685
    Crossref
  4. Outcome Prediction by Combining Corticospinal Tract Lesion Load with Diffusion-tensor Fractional Anisotropy in Patients after Hemorrhagic Stroke, Progress in Rehabilitation Medicine, 9, 0, (n/a), (2024).https://doi.org/10.2490/prm.20240001
    Crossref
  5. NSF DARE—Transforming modeling in neurorehabilitation: Four threads for catalyzing progress, Journal of NeuroEngineering and Rehabilitation, 21, 1, (2024).https://doi.org/10.1186/s12984-024-01324-x
    Crossref
  6. Cross-Frequency Coupling as a Biomarker for Early Stroke Recovery, Neurorehabilitation and Neural Repair, 38, 7, (506-517), (2024).https://doi.org/10.1177/15459683241257523
    Crossref
  7. Point of View on Outcome Prediction Models in Post-Stroke Motor Recovery, Neurorehabilitation and Neural Repair, 38, 5, (386-398), (2024).https://doi.org/10.1177/15459683241237975
    Crossref
  8. Correlations in abnormal synergies between the upper and lower extremities across various phases of stroke, Journal of Neurophysiology, 132, 1, (87-95), (2024).https://doi.org/10.1152/jn.00102.2024
    Crossref
  9. Evidence of the existence of multiple modules for the stroke-caused flexion synergy from Fugl-Meyer assessment scores, Journal of Neurophysiology, 132, 1, (78-86), (2024).https://doi.org/10.1152/jn.00067.2024
    Crossref
  10. Bilateral effect of acupuncture on cerebrum and cerebellum in ischaemic stroke patients with hemiparesis: a randomised clinical and neuroimaging trial, Stroke and Vascular Neurology, 9, 3, (306-317), (2024).https://doi.org/10.1136/svn-2023-002785
    Crossref
  11. See more
Loading...

View Options

View options

PDF and All Supplements

Download PDF and All Supplements

PDF/EPUB

View PDF/EPUB
Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to access the full text.

Purchase access to this article for 24 hours

Corticospinal Tract Injury Estimated From Acute Stroke Imaging Predicts Upper Extremity Motor Recovery After Stroke
Stroke
  • Vol. 50
  • No. 12

Purchase access to this journal for 24 hours

Stroke
  • Vol. 50
  • No. 12
Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

Media

Figures

Other

Tables

Share

Share

Share article link

Share

Comment Response